China SXT Pharmaceuticals (SXTC) Other financing activities (2018 - 2024)
Historic Other financing activities for China SXT Pharmaceuticals (SXTC) over the last 7 years, with Q3 2024 value amounting to $33.4 million.
- China SXT Pharmaceuticals' Other financing activities fell 712.23% to $33.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $33.4 million, marking a year-over-year decrease of 712.23%. This contributed to the annual value of $135000.0 for FY2025, which is 9961.77% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Other financing activities of $33.4 million as of Q3 2024, which was down 712.23% from $35.3 million recorded in Q1 2024.
- China SXT Pharmaceuticals' Other financing activities' 5-year high stood at $35.9 million during Q3 2023, with a 5-year trough of $17.2 million in Q1 2020.
- For the 5-year period, China SXT Pharmaceuticals' Other financing activities averaged around $29.7 million, with its median value being $31.8 million (2022).
- In the last 5 years, China SXT Pharmaceuticals' Other financing activities skyrocketed by 11584.48% in 2020 and then tumbled by 712.23% in 2024.
- China SXT Pharmaceuticals' Other financing activities (Quarter) stood at $24.2 million in 2020, then grew by 7.33% to $26.0 million in 2021, then rose by 25.2% to $32.6 million in 2022, then rose by 10.4% to $35.9 million in 2023, then decreased by 7.12% to $33.4 million in 2024.
- Its last three reported values are $33.4 million in Q3 2024, $35.3 million for Q1 2024, and $35.9 million during Q3 2023.